Suppr超能文献

包括一氧化氮在内的血管舒张剂对离体灌注大鼠肾脏中cGMP和cAMP释放的影响。

Effect of vasodilators, including nitric oxide, on the release of cGMP and cAMP in the isolated perfused rat kidney.

作者信息

Heuzé-Joubert I, Mennecier P, Simonet S, Laubie M, Verbeuren T J

机构信息

Servier Research Institute, Department of Angiology, Suresnes, France.

出版信息

Eur J Pharmacol. 1992 Sep 22;220(2-3):161-71. doi: 10.1016/0014-2999(92)90744-o.

Abstract

In isolated Tyrode-perfused rat kidneys, the release of the cyclic nucleotides cAMP and cGMP was measured in response to several vasodilators, including nitric oxide (NO). During vasoconstrictions induced by methoxamine, a basal release of both cyclic nucleotides was detected in the renal effluent (357 +/- 32 fmol/min for cGMP and 3097 +/- 219 fmol/min for cAMP). Injection of acetylcholine (ACh; 11 nmol), sodium nitroprusside (SNP; 0.8 nmol) and atrial natriuretic factor (ANF; 80 pmol) caused a marked release of cGMP. The cGMP release induced by ACh was not altered by indomethacin (3 microM) but was markedly reduced by the NO synthase inhibitor nitro-L-arginine (L-NNA; 200 microM). Authentic NO (0.16-80 nmol) caused dose-dependent vasodilatations that were accompanied by increases in the overflow of cGMP. The vasodilatations caused by forskolin (6 nmol) and prostacyclin (PGI2; 3-52 nmol) were not accompanied by an overflow of cGMP. The vasodilator responses to 5-hydroxytryptamine (5-HT; 0.25-2 mumol), obtained in presence of the 5-HT2 receptor blocker ritanserin (10 nM) and the 5-HT3 blocker ICS 205930 (10 nM), were markedly reduced by L-NNA; however, they were not accompanied by the renal release of cGMP. Both forskolin and PGI2 induced the release of cAMP from perfused rat kidneys; ACh, 5-HT and 5-carboxamidotryptamine (5-CT) also evoked a significant release of cAMP into the renal effluent. The release of cAMP induced by ACh and 5-HT was reduced by indomethacin and L-NNA. Higher doses of NO released cAMP from the perfused rat kidneys. Our data illustrate that both cAMP and cGMP can be released by vasodilator substances into the venous effluent of isolated perfused rat kidneys. The dilator responses to 5-HT were sensitive to the NO synthase inhibitor L-NNA and were accompanied by the release of cAMP and not by the release of cGMP. Our data suggest that the dilator responses may be due to NO released from endothelial cells, which then activates adenylyl cyclase either directly or indirectly.

摘要

在离体用台氏液灌注的大鼠肾脏中,检测了环核苷酸cAMP和cGMP对几种血管舒张剂(包括一氧化氮(NO))的反应释放量。在甲氧明诱导的血管收缩过程中,在肾流出液中检测到两种环核苷酸的基础释放量(cGMP为357±32 fmol/分钟,cAMP为3097±219 fmol/分钟)。注射乙酰胆碱(ACh;11 nmol)、硝普钠(SNP;0.8 nmol)和心房利钠因子(ANF;80 pmol)可导致cGMP的显著释放。吲哚美辛(3 μM)不改变ACh诱导的cGMP释放,但一氧化氮合酶抑制剂硝基-L-精氨酸(L-NNA;200 μM)可使其显著降低。纯NO(0.16 - 80 nmol)引起剂量依赖性血管舒张,同时伴有cGMP溢出增加。福斯可林(6 nmol)和前列环素(PGI2;3 - 52 nmol)引起的血管舒张不伴有cGMP溢出。在5-羟色胺2(5-HT2)受体阻滞剂利坦色林(10 nM)和5-羟色胺3(5-HT3)阻滞剂ICS 205930(10 nM)存在的情况下,对5-羟色胺(5-HT;0.25 - 2 μmol)的血管舒张反应被L-NNA显著降低;然而,它们不伴有肾脏cGMP释放。福斯可林和PGI2均可诱导灌注大鼠肾脏释放cAMP;ACh、5-HT和5-羧酰胺色胺(5-CT)也可引起cAMP显著释放到肾流出液中。吲哚美辛和L-NNA可降低ACh和5-HT诱导的cAMP释放。更高剂量的NO可使灌注大鼠肾脏释放cAMP。我们的数据表明,血管舒张剂可使cAMP和cGMP释放到离体灌注大鼠肾脏的静脉流出液中。对5-HT的舒张反应对一氧化氮合酶抑制剂L-NNA敏感,且伴有cAMP释放而非cGMP释放。我们的数据表明,舒张反应可能是由于内皮细胞释放的NO,其随后直接或间接激活腺苷酸环化酶。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验